BioCentury

BioCentury This Week

Science EN ↓ 402 episodes

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Be sure to visit the podcast's website and support the creator: www.biocentury.com

Author

BioCentury

Category

Science

Podcast website

www.biocentury.com

Latest episode

Oct 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android almost 10M downloads · 4.8 rating iOS soon

Episodes

Ep. 52 - Memories of John Martin, plus AACR's Hot Targets & Bio€quity Europe Preview 06.04.2021

Reach us by sending a text

Ep. 51 - Abernethy & the Obvious at FDA; Plus CEPI & EpimAb 30.03.2021

Reach us by sending a text

Ep. 50 - FTC & the Zombie Pharma Dinosaurs; Plus: RIP José Baselga, NCATS & SPACs 23.03.2021

Reach us by sending a text

Ep. 49 - Vaccine Vexed; Plus Assessing Lilly's Alzheimer's Data & PDUFA Preview 16.03.2021

Reach us by sending a text

Ep. 48 - New Modality Deep Dive; plus Sharpless Speaks & Five Prime Scores 09.03.2021

Reach us by sending a text

Ep. 47 - Whither Woodcock; plus Refresh for German Biotech & Modalities to Market 02.03.2021

Reach us by sending a text

Ep. 46 - Pipeline plays for BMS, Rigel; plus J&J's vaccine panel & access for Africa 23.02.2021

Reach us by sending a text

Ep. 45 - Start-Up Trends, COVID Variants and J&J's Adcomm 17.02.2021

Reach us by sending a text

Ep. 44 - Biotech's IPO blizzard, plus GameStop, Porter Report & Vaccine Guidance 09.02.2021

Reach us by sending a text

Ep. 43 - Europe's Next Act & the Porter Report 02.02.2021

Reach us by sending a text

Ep. 42 - Warp Speed Reflections, Master Protocols & Biden’s COVID Plan 25.01.2021

Reach us by sending a text

Ep. 41 - Biden's Science Team; Plus: Early Cancer Detection 20.01.2021

Reach us by sending a text

Ep. 40 - Investors' Picks & Access to Capital in 2021 15.01.2021

Reach us by sending a text

Ep. 39 - COVID Accountability, Biden's Bidding & Start-up Season 12.01.2021

Reach us by sending a text

Ep. 38 - Crucible of COVID, Ahoy 2021 & Cancer Deal Trends 05.01.2021

Reach us by sending a text

Ep. 37 - 2020's Silver Linings, New Year's Hopes 29.12.2020

Reach us by sending a text

Ep. 36 - Vaccines march forward & CAR Ts move earlier: a BioCentury podcast 15.12.2020

Reach us by sending a text

Ep. 35 - ASH Monday, Biden's Picks & Vaccine Conundrums 08.12.2020

Reach us by sending a text

Ep. 34 - Moderna Moves & Immunocore Breaks Through 01.12.2020

Reach us by sending a text

Ep. 33 - ASH Preview & Long Shot Drug Pricing Rule 24.11.2020

Reach us by sending a text

Ep. 32 - Moderna Times & China's Future 17.11.2020

Reach us by sending a text

Ep. 31 - Pfizer & Biogen: The Good, the bAD and What's Next 10.11.2020

Reach us by sending a text

Ep. 30 - ICER's Influence and Election Effects 03.11.2020

Reach us by sending a text

Ep. 29 - SPACs & Vax 27.10.2020

Reach us by sending a text

Ep. 28 - FDA's Future & China Summit Preview 20.10.2020

Reach us by sending a text

Listen to the BioCentury This Week podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.